We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




All-in-One Device Increases Bedside Spirometry Testing

By HospiMedica International staff writers
Posted on 19 Jun 2017
A new spirometry solution helps primary care physicians conduct lung function testing at the point of care (POC).

The EasyOne Air is a portable, connected spirometry device that requires no calibration, warm-up time, or maintenance. More...
An intuitive, full-color touch screen display ensures accurate and immediate results through real-time curves and parameters. The device connects via USB to a computer for direct printing and downloading, with an added option of portability through a secure Bluetooth connection, providing seamless integration to the patients’ electronic medical record (EMR) via EasyOne Connect, a platform for all EasyOne point-of-care solutions.

EasyOne Air is powered by propriety ultrasound flow technology that anticipates interfering variables, allowing it to function independently of gas composition, pressure, temperature, and humidity, thus ensuring a consistent, standardized test that is based on American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. Test types include FVC, FVL, SVC, MVV, and Pre/Post Testing. EasyOne Air is a product of ndd Medical Technologies (Zurich, Switzerland), and has been approved by the U.S. Food and Drug Administration (FDA).

“EasyOne Air is a flexible and reliable tool for healthcare professionals to accurately diagnose lung health. This new model includes ndd’s TrueFlow technology for the most accurate way to diagnose the growing number of patients suffering from COPD and other chronic lung diseases,” said Georg Harnoncourt, CEO of ndd Medical Technologies. “The earlier a physician can diagnose a patient, the faster they can offer treatment. The sooner a patient begins treatment, the better their quality of life.”

Spirometry is the most common pulmonary function test (PFT); it measures lung function, specifically the volume and/or flow of air inhaled and exhaled, which is helpful in assessing breathing patterns that identify conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Spirometry generates pneumotachograph charts that plot the volume and flow of air coming in and out of the lungs from one inhalation and one exhalation.

Related Links:
ndd Medical Technologies


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.